PE-22-28 is a synthetic, shortened derivative of spadin that selectively inhibits TREK-1 potassium channels, showing rapid-onset neurogenic and antidepress
Read more PE-22-28 Research Peptide: Mechanism, TREK-1 Blockade, and Preclinical Evidence
PE-22-28 Research Peptide: Mechanism, TREK-1 Blockade, and Preclinical Evidence